Aura Biosciences, Inc. logo

AURA Earnings Date: Nov 5, 2026 (Estimated) — Aura Biosciences, Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $6.20
Market Cap $643.0M
P/E -3.5
52W Range $4.73 – $9.54
Next Earnings · Before open (est.)

When is AURA's next earnings date?

Aura Biosciences, Inc. (AURA) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.37.

How did AURA do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Aura Biosciences, Inc. posted EPS of -$0.48 versus the -$0.38 estimate, a miss of 26.3%. Revenue was $0. The stock's 1-day post-earnings move was +4.4%.

How much does AURA stock move after earnings?

AURA beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.0% (up or down) in the day after earnings.

About Aura Biosciences, Inc.

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-11Q2 2026-0.38-0.48-26.32%$0❌ Miss+4.42%-0.26%-6.49%
2026-05-11Q1 2026-0.40-0.50-25.00%$0❌ Miss-3.17%-8.79%-25.27%
2026-03-30Q4 2025-0.43-0.37+13.95%$0✅ Beat-1.12%+6.54%+11.00%
2025-11-13Q3 2025-0.46-0.40+13.04%$0✅ Beat-0.72%-3.05%+17.41%
2025-08-13Q2 2025-0.49-0.47+4.08%$0✅ Beat+4.18%-7.78%-4.32%
2025-03-24Q4 2024-0.43-0.52-20.93%$0❌ Miss+1.14%-16.29%-17.71%
2024-03-27Q4 2023-1.82-0.50+72.53%$0✅ Beat+0.92%-4.33%-7.21%
2023-05-11Q1 2023-0.54-0.46+14.81%$0✅ Beat+0.39%+16.36%+22.53%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .